Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04481178
Other study ID # si347/2020
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date September 15, 2020
Est. completion date December 1, 2020

Study information

Verified date September 2020
Source Mahidol University
Contact Prof. Woraphong Manuskiatti, M.D.
Phone +6624197000
Email woraphong.man@mahidol.ac.th
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A retrospective study on efficacy and complication of laser treatment (Q-switched Nd:YAG and picosecond laser) of nevus of Ota in Thai patients


Description:

Nevus of Ota is a benign dermal melanocytic nevus found most commonly in Asians. About 50-60% of all cases have the age of onset at birth or within the first year of life, others appear before puberty. It typically presents as a unilateral mottled blue-gray macules and patches distributed along the first and second branches of trigeminal nerve. Due to its marked hyperpigmentation on the face which does not resolved spontaneously, patients may experience psychosocial disturbances and often seek for treatments. Based on selective photothermolysis theory, Q-switched lasers (ruby 694nm, alexandrite 755nm, Nd:YAG 1064nm) have been used for the treatment of nevus of Ota with a success rate of 95% after 6-8 sessions. Reported complications from the lasers are hypopigmentation(15.3%), hyperpigmentation(2.9%), texture changes (2.9%), and scarring (1.9%). Siriraj Skin Laser Center provides laser treatment for nevus of Ota using mainly Q-switched Nd:YAG laser and Picosecond laser. The study of efficacy and complications of Q-switched Nd:YAG and Picosecond laser in the treatment of Nevus of Ota in Thai patients has never been reported. Therefore, we conduct a retrospective study on efficacy and complication of laser treatment (Q-switched Nd:YAG and picosecond laser) of nevus of Ota in Thai patients.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 79
Est. completion date December 1, 2020
Est. primary completion date October 1, 2020
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patient with Nevus of Ota

- Complete data between January 2008 - December 2018

Exclusion Criteria:

- Incomplete data

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Laser (QS, Picosecond laser)
QS-Nd Yag Laser, Picosecond laser

Locations

Country Name City State
Thailand Faculty of Medicine Siriraj Hospital Bangkoknoi Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

Outcome

Type Measure Description Time frame Safety issue
Primary Efficacy of laser treatment in paitients with Nevus of Ota Fading of lesions after treatment by chart review 2008-2018
Secondary Complication of laser such as hyperpigmentation, hypopigmentation, and scars Complication of laser such as hyperpigmentation, hypopigmentation, and scars 2008-2018
Secondary Relapse rate after laser treatment rate of recurrence after treatment 2008-2018